| 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer FC Hamdy, JL Donovan, JA Lane, M Mason, C Metcalfe, P Holding, ... New England Journal of Medicine 375 (15), 1415-1424, 2016 | 3082 | 2016 |
| Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer JL Donovan, FC Hamdy, JA Lane, M Mason, C Metcalfe, E Walsh, ... New England Journal of Medicine 375 (15), 1425-1437, 2016 | 1403 | 2016 |
| The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer JC Smith, S Bennett, LM Evans, HG Kynaston, M Parmar, MD Mason, ... The Journal of Clinical Endocrinology & Metabolism 86 (9), 4261-4267, 2001 | 548 | 2001 |
| An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer G Van Andel, A Bottomley, SD Fosså, F Efficace, C Coens, S Guerif, ... European journal of cancer 44 (16), 2418-2424, 2008 | 535 | 2008 |
| Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes JP Webber, LK Spary, AJ Sanders, R Chowdhury, WG Jiang, R Steadman, ... Oncogene 34 (3), 290-302, 2015 | 514 | 2015 |
| Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer FC Hamdy, JL Donovan, JA Lane, C Metcalfe, M Davis, EL Turner, ... New England Journal of Medicine 388 (17), 1547-1558, 2023 | 397 | 2023 |
| Intravesical bacillus Calmette‐Guerin is superior to mitomycin C in reducing tumour recurrence in high‐risk superficial bladder cancer: a meta‐analysis of randomized trials MD Shelley, TJ Wilt, J Court, B Coles, H Kynaston, MD Mason BJU international 93 (4), 485-490, 2004 | 339 | 2004 |
| Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial CC Parker, NW Clarke, AD Cook, HG Kynaston, PM Petersen, C Catton, ... The Lancet 396 (10260), 1413-1421, 2020 | 332 | 2020 |
| A systematic review of intravesical bacillus Calmette‐Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer MD Shelley, H Kynaston, J Court, TJ Wilt, B Coles, K Burgon, MD Mason BJU international 88 (3), 209-216, 2001 | 312 | 2001 |
| Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses MD Shelley, MD Mason, H Kynaston Cancer treatment reviews 36 (3), 195-205, 2010 | 240 | 2010 |
| Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells E Elkord, PE Williams, H Kynaston, AW Rowbottom Immunology 114 (2), 204-212, 2005 | 216 | 2005 |
| The prevalence and predictors of psychological distress in patients with early localized prostate cancer JI Bisson, HL Chubb, S Bennett, M Mason, D Jones, H Kynaston BJU international 90 (1), 56-61, 2002 | 207 | 2002 |
| Court J, Wilt TJ, Coles B, Burgon K, et al. A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and … MD Shelley, H Kynaston BJU Int 88 (3), 209-16, 2001 | 182 | 2001 |
| Intravesical gemcitabine therapy for non‐muscle invasive bladder cancer (NMIBC): a systematic review MD Shelley, G Jones, A Cleves, TJ Wilt, MD Mason, HG Kynaston BJU international 109 (4), 496-505, 2012 | 168 | 2012 |
| ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common … C Coyle, FH Cafferty, S Rowley, M MacKenzie, L Berkman, S Gupta, ... Contemporary clinical trials 51, 56-64, 2016 | 163 | 2016 |
| Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to … DE Neal, C Metcalfe, JL Donovan, JA Lane, M Davis, GJ Young, ... European urology 77 (3), 320-330, 2020 | 162 | 2020 |
| Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of … C Parker, MR Sydes, C Catton, H Kynaston, J Logue, C Murphy, ... BJU international 99 (6), 2007 | 159 | 2007 |
| RADICALS (radiotherapy and androgen deprivation in combination after local surgery) C Parker, N Clarke, J Logue, H Payne, C Catton, H Kynaston, C Murphy, ... Clinical Oncology 19 (3), 167-171, 2007 | 138 | 2007 |
| Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4 L Ye, H Kynaston, WG Jiang Molecular cancer research 6 (10), 1594-1606, 2008 | 134 | 2008 |
| Intravesical bacillus Calmette‐Guerin in Ta and T1 bladder cancer M Shelley, JB Court, H Kynaston, TJ Wilt, R Fish, M Mason, ... Cochrane Database of Systematic Reviews 2010 (3), 1996 | 134 | 1996 |
